BGNE250117P175000
- 7.20
- 0.000.00%
BeiGene Newsroom
News On BeiGene Ltd. (BGNE) Now Under ONC
Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene
BEIGENE (06160.HK) issued 0.1032 million shares due to the vesting of restricted stock units.
On December 30th, Gelonghui announced that BEIGENE (06160.HK) will issue 0.1032 million ordinary shares on December 29, 2024, due to the vesting of restricted stock units granted under the equity plan (excluding company directors).
The Market Doesn't Like What It Sees From BeiGene, Ltd.'s (NASDAQ:BGNE) Revenues Yet
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Markets Sluggishly Move to Year-End
BeiGene Gains FDA Nod for TEVIMBRA, Marking Key Progress in Oncology Treatments
TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination With Chemotherapy
BeiGene to Rebrand as BeOne Medicines With Oncology-Focused New Nasdaq Ticker "ONC"
BeiGene to Change Nasdaq Ticker Symbol to "ONC" on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
Express News | Beigene to Change Nasdaq Ticker Symbol to “Onc” on January 2; Present at 43Rd Annual J.P. Morgan Healthcare Conference
BeiGene Gets FDA Orphan Designation in Waldenstrom Macroglobulinemia Treatment
TD Cowen Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $260
BeiGene (BGNE) Gets a Buy From TD Cowen
BeiGene: Promising Growth Trajectory and Investment Opportunity Backed by Strong Product Pipeline and Robust Financials
Selected announcements | Ping An Insurance's original premium income in the current year is nearly 800 billion yuan; GANFENGLITHIUM's Goulamina spodumene project phase one has officially gone into production.
In the first 11 months, New China Life Insurance accumulated original insurance premium income of 163.1663 billion yuan, a year-on-year increase of 2.2%; Ideal Autos granted a total of 3.94697 million restricted stock units.
BEIGENE (06160.HK) issued 1.3 million shares due to the exercise of stock options.
Gelonghui reported on December 16 that BEIGENE (06160.HK) announced the issuance of 1.3 million ordinary shares due to a Director exercising stock options on December 14, 2024.
Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio?
Sector Update: Health Care Stocks Steady Premarket Friday
Sector Update: Health Care
CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland